1. Home
  2. MBIN vs STOK Comparison

MBIN vs STOK Comparison

Compare MBIN & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIN

Merchants Bancorp

HOLD

Current Price

$46.64

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.85

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIN
STOK
Founded
1990
2014
Country
United States
United States
Employees
735
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MBIN
STOK
Price
$46.64
$29.85
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$43.67
$39.20
AVG Volume (30 Days)
116.5K
448.5K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
0.89%
N/A
EPS Growth
N/A
92.73
EPS
N/A
N/A
Revenue
N/A
$184,420,000.00
Revenue This Year
$31.76
N/A
Revenue Next Year
$3.73
$77.49
P/E Ratio
$12.29
N/A
Revenue Growth
N/A
404.50
52 Week Low
$28.75
$9.09
52 Week High
$50.26
$40.22

Technical Indicators

Market Signals
Indicator
MBIN
STOK
Relative Strength Index (RSI) 53.57 35.82
Support Level $45.12 $25.21
Resistance Level $48.50 $35.11
Average True Range (ATR) 1.32 1.65
MACD -0.12 -0.29
Stochastic Oscillator 74.36 25.28

Price Performance

Historical Comparison
MBIN
STOK

About MBIN Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: